Revenue nearly doubled and losses narrowed as OptiCept accelerated commercialization, secured major orders, and strengthened its financial position through a rights issue and refinancing, but liquidity risk remains elevated.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.